Legacy Effects of Baseline Blood Pressure 'Treatment Naivety' on All-cause and Cardiovascular Mortality in the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

被引：0
|
作者：
Ho, Chau
Bresliln, Monique
Chowdhury, Enayet
Doust, Jenny
Reid, Christopher M.
Davis, Barry R.
Simpson, Lara M.
Nelson, Mark R.
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11020
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone - The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Furberg, CD
    Wright, JT
    Davis, BR
    Cutler, JA
    Alderman, M
    Black, H
    Cushman, W
    Grimm, R
    Haywood, LJ
    Leenen, F
    Oparil, S
    Perry, HM
    Probstfield, J
    Whelton, P
    Payne, G
    Nwachuku, C
    Gordon, D
    Proschan, M
    Frommer, P
    Einhorn, P
    Hawkins, M
    Ford, C
    Pressel, S
    Piller, L
    Lusk, C
    Bettencourt, J
    Kimmel, B
    Geraci, T
    Walsh, S
    Rahman, M
    Juratovac, A
    Pospisil, R
    Brennan, K
    Carroll, L
    Sullivan, S
    Barone, G
    Christian, R
    Feldman, S
    Lucente, T
    Lewis, CE
    Jenkins, K
    McDowell, P
    Johnson, J
    Kingry, C
    Letterer, R
    Margolis, K
    Holland, L
    Jaeger-Fox, B
    Williamson, J
    Louis, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (15): : 1967 - 1975
  • [32] Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])
    Alderman, Michael H.
    Davis, Barry R.
    Piller, Linda B.
    Ford, Charles E.
    Baraniuk, M. Sarah
    Pressel, Sara L.
    Assadi, Mahshid A.
    Einhorn, Paula T.
    Haywood, L. Julian
    Ilamathi, Ekambaram
    Oparil, Suzanne
    Retta, Tamrat M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (01): : 105 - 115
  • [33] The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT): The largest hypertension study ever undertaken: Baseline characteristics
    Grimm, RH
    Davis, BR
    Ford, C
    Alderman, MH
    Black, HR
    Cushman, WC
    Dequattro, V
    Papademetriou, V
    CIRCULATION, 1997, 96 (08) : 1542 - 1542
  • [34] Heart failure with preserved and impaired left ventricular systolic function in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Davis, Barry R.
    Simpson, Lara M.
    Black, Henry R.
    Cushman, Wililam C.
    Einhorn, Paula T.
    Farber, Michael A.
    Ford, Charles E.
    Levy, Daniel
    Massie, Barry M.
    Nawaz, Shah
    Nawaz, Shah
    CIRCULATION, 2006, 114 (18) : 571 - 571
  • [35] THE EFFECT OF RENAL FUNCTION ON INCIDENCE OF CONGESTIVE HEART FAILURE: THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) STUDY
    Kholghi, Maedeh Khayyat
    Oparil, Suzanne
    Davis, Barry
    Tereshchenko, Larisa G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 752 - 752
  • [36] Relationship of 1 year hypokalemia incidence to clinical outcomes in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Alderman, Michael
    Calhoun, David
    Cushman, William
    Davis, Barry
    Eckfeldt, John
    Einhorn, Paula
    Ford, Charles
    Franklin, Stanley
    Furberg, Curt
    Ong, Stephen
    Oparil, Suzanne
    Papademetriou, Vasilios
    Piller, Linda
    Probstfield, Jeffrey
    CIRCULATION, 2006, 114 (18) : 576 - 576
  • [37] Follow-up specialists in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Contribution to study closeout
    Pressel, S
    Davis, B
    Blanton, J
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 116S - 117S
  • [38] Cardiovascular outcomes in hypertensives with coronary artery disease randomized to amlodipine versus lisinopril in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Leenen, F
    Nwachuku, C
    Cushman, W
    Black, H
    Simpson, L
    Davis, B
    JOURNAL OF HYPERTENSION, 2005, 23 : S21 - S22
  • [39] Baseline Quality of Life and Risk of Stroke in the Antihypertensive and Lipid Lowering to Prevent Heart Attack (ALLHAT) Trial
    Shams, Tanzila
    Auchus, Alexander P.
    Oparil, Suzanne
    Wright, Clinton
    Wright, Jackson
    Furlan, Anthony J.
    Sila, Cathy A.
    Davis, Barry
    Pressel, Sara
    Yamal, Jose-Miguel
    Einhorn, Paula
    Cutler, Jeff
    Lerner, Alan J.
    STROKE, 2015, 46
  • [40] Clinical outcomes in participants with cardiovascular dysmetabolic syndrome in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Davis, BR
    Black, HR
    CIRCULATION, 2004, 110 (17) : 796 - 796
12345